Bipolar Disorder and Cognitive Function: Memory, Attention, and Daily Life
Author: Ukrainian Psychological Hub · Published: October 9, 2026 · Editorial Policy
Bipolar disorder can influence attention, memory, processing speed, learning, planning, and the mental flexibility needed for everyday decisions. Some difficulties appear during depressive or manic episodes; other changes can remain when mood is relatively stable. The pattern and severity vary greatly between individuals. Studying cognition therefore helps explain experiences that are easily overlooked by a focus on mood alone, including challenges at work, in education, and with maintaining ordinary routines. 2025 meta-analysis · 2026 functioning meta-analysis
A cognitive complaint is meaningful, but it is not a diagnosis. Forgetting appointments, losing concentration, or feeling mentally slow cannot establish bipolar disorder; clinicians diagnose bipolar conditions through the longitudinal history of distinct mood-and-energy episodes, associated impairments, and differential assessment. Sleep loss, anxiety, depression, ADHD, medication effects, substance use, medical problems, and ordinary life stress can also affect thinking. NIMH clinical overview · NICE clinical guidance
This guide addresses the cognitive dimension of bipolar illness: what research has established, how performance differs among people and across episodes, whether deterioration is inevitable, how clinicians evaluate symptoms, what interventions actually help, and which daily adjustments may reduce their impact. For foundational diagnostic categories and episodes, consult Bipolar Disorder: Symptoms, Types, Diagnosis, and Treatment.
For additional clinical context, see Does Bipolar Disorder Get Worse With Age? Long-Term Course and Outcomes.
What Does Cognitive Function Mean in Bipolar Disorder?
Cognitive function describes the mental processes used to understand, store, retrieve, and act on information. Neuropsychological research divides these processes into partially overlapping domains. A person may do well in one and struggle in another. A single phrase such as brain fog often contains several experiences: distractibility, unusually slow thought, difficulties retrieving words, mental fatigue, or losing track of a sequence. A detailed account can identify the processes most relevant to daily life. International Society for Bipolar Disorders recommendations
Verbal memory, visual memory, and learning
Verbal memory supports remembering explanations, conversations, names, and information read or heard. Visual memory supports retaining images, layouts, routes, and spatial arrangements. Learning requires initially encoding information, which itself depends on attention. Some people describe hearing instructions accurately but later being unable to recall them, forgetting parts of conversations, or needing more repetitions to learn new material. Reviews find average differences in both verbal and visuospatial memory in euthymic bipolar samples. Swidzinski et al., 2025
The distinction between encoding and retrieval is important. A person distracted during a conversation may never have encoded its details adequately. Another person may retain information but have difficulty retrieving it without a cue. A neuropsychological examination can explore these differences, while written instructions, notes, repetition, and cueing may help with practical problems. Individual reports should be assessed rather than assumed to have one universal mechanism. ISBD clinical recommendations
Working memory and attention
Working memory temporarily holds and manipulates information: keeping two instructions in mind while completing a third, calculating a total mentally, or following a long sentence. Sustained attention supports focus across time; selective attention allows important information to remain prominent amid competing stimulation. Difficulty in these systems can make multitasking inefficient, increase mistakes, and make seemingly small tasks exhausting. The pooled research on euthymic bipolar disorder identifies working memory and attention/processing speed among affected domains. Swidzinski et al., 2025
Attention is highly sensitive to state. In bipolar depression, reduced concentration and slower thinking may accompany low motivation or poor sleep. In mania or hypomania, subjective mental acceleration may be accompanied by distractibility and impaired judgment. A person feeling exceptionally fast is not necessarily processing information accurately. Clinical assessment links cognition to the current mood-and-sleep state. NIMH
Processing speed
Processing speed describes how efficiently someone performs comparatively simple mental tasks under controlled conditions. In daily life, reduced speed may feel like needing longer to respond in meetings, read dense documents, switch tasks, or follow quick conversation. Speed measures are influenced by concentration, fatigue, medication, motor demands, and the particular task. Reviews have reported measurable processing-speed differences in bipolar disorder, including when mood symptoms are relatively quiet. Little et al., 2024 · Swidzinski et al., 2025
Executive functions
Executive functions include organizing tasks, planning multiple steps, inhibiting distractions or impulses, recognizing mistakes, switching strategies, and managing priorities. Someone may retain substantial knowledge yet struggle to translate it into reliable action: completing an invoice, planning a journey, or breaking a large assignment into workable stages. These difficulties can coexist with strong reasoning, education, creativity, and professional skills. Group differences in executive functioning are documented in meta-analytic research, but an individual profile must be tested rather than assumed. Swidzinski et al., 2025
Social cognition
Social cognition includes interpreting expressions, emotion, context, and others' intentions. Its practical role can be seen in following subtle conversation or understanding feedback when under strain. Research distinguishes social cognition from general memory and executive skills. A 2026 meta-analysis found associations between both social and nonsocial cognitive performance and everyday functioning, although average correlations were modest; interpreting relationships also requires attention to mood, context, conflict, communication habits, and opportunity. McCleery et al., 2026
What Do Large Studies Actually Show?
Cognitive differences can persist during euthymia
Euthymia refers to a period without a current full manic or depressive episode. It does not promise the absence of every residual symptom. A 2025 systematic review and meta-analysis combined 75 studies, with 4,404 euthymic participants with bipolar disorder and 4,037 healthy controls. Average standardized group differences were found for general cognition (Hedges' g = −0.58), verbal memory (−0.70), executive function (−0.69), visuospatial memory (−0.68), attention/processing speed (−0.64), and working memory (−0.61). These effect sizes represent group contrasts, not the percentage of individuals impaired. Swidzinski et al., 2025
The review also documented substantial heterogeneity. Cognitive assessments, education, illness histories, subthreshold symptoms, and treatment exposure varied across samples, and much of the variation was unexplained. The pooled estimates should not be used to predict whether an individual will have severe disability, how long symptoms will last, or whether medication caused a problem. They establish an important population-level observation: relatively stable mood and entirely typical test performance are not identical concepts. Swidzinski et al., 2025
Cognitive difficulty is not universal or uniform
A 2025 meta-analysis of data-driven cognitive subgroups found recurring patterns of good, moderately reduced, and more substantially reduced test performance. Across the included cross-sectional studies, pooled subgroup estimates were roughly one-third relatively high-functioning, two-fifths moderately affected, and about one-quarter more severely affected. Those figures summarize selected research samples and analytical approaches; they are not diagnostic thresholds, population prevalence estimates, or labels to assign to an individual. Bora et al., 2025
Different tests may highlight different strengths and difficulties. Some people notice little cognitive change even during sustained recovery, whereas others experience difficulties disproportionate to mood symptoms. Age, baseline ability, illness experience, education, anxiety, sleep, medical status, and adverse effects may influence observed results. The diagnostic distinction between bipolar I and bipolar II does not, on its own, determine a person's cognitive profile. Bora et al., 2025 · ISBD recommendations
The association with everyday functioning is significant but modest
A 2026 systematic review and multilevel meta-analysis synthesized 103 reports encompassing 2,200 effect sizes and 9,323 adults with bipolar disorder. Better overall cognitive performance was associated with better overall daily functioning at r = .20. On average, the association corresponds to approximately 4% shared variance. Nonsocial cognition had a somewhat stronger average association with functioning (r = .21) than social cognition (r = .16). The size of the relationship depended on measurement domains and participant characteristics. McCleery et al., 2026
The implication is clinically important: laboratory test results explain only one portion of a person's experience. Symptoms, stable housing, job demands, access to treatment, physical health, income, sleep, social support, and available accommodations can make a substantial difference. Someone may score within typical ranges yet struggle with a fast-paced unpredictable workplace; another may score below a comparison mean and perform effectively with established routines. A test result must not be treated as a verdict on independence or capability. McCleery et al., 2026
Feeling cognitively worse and testing worse are different measurements
Self-reported cognitive complaints describe what people experience in their own settings. Neuropsychological tests measure performance on standardized tasks at one point in time. A 2026 meta-analysis found that these two perspectives show generally weak correlations across mood disorders. A separate 2026 bipolar-disorder study involving hundreds of patients found that subjective complaints could reflect estimated decline from a person's previous cognitive level even when current scores remained within broad normative ranges. Eggleston et al., 2026 · Schandorff et al., 2026
A former high-performing student may remain above the average standardized test threshold while experiencing a real reduction in efficiency. Conversely, measurable difficulties can appear in someone who notices few problems. Good care uses both perspectives, along with daily functioning and the clinical timeline, rather than dismissing subjective distress because a brief test looks reassuring or inferring disability from a self-report alone. Schandorff et al., 2026
How Do Cognitive Symptoms Differ Across Mood Episodes?
During bipolar depression
Depressive episodes can involve concentration difficulties, slower thought, indecision, low motivation, fatigue, and impaired recall. Some problems result from mood symptoms directly; others reflect associated sleep disturbance or reduced engagement with information. As depression improves, certain cognitive symptoms may also improve, although separate interepisode difficulties can remain. Treatment choices must reflect a bipolar depressive episode rather than applying unipolar depression medication assumptions. NIMH · CANMAT/ISBD 2023 evidence update
During mania or hypomania
Mania may involve reduced need for sleep, increased energy, rapid speech, racing thoughts, distractibility, impulsivity, and unsafe decisions. Hypomania is a distinct mood episode with different severity criteria; it cannot be equated with full mania, and bipolar II is not merely a mild form of bipolar I. Subjective feelings of clarity or unusually rapid association during activation do not establish accurate attention, memory, inhibition, or judgment. Severe mania, psychosis, or inability to maintain safety calls for urgent specialist care. NIMH · VA/DoD clinical guideline
Mixed features and residual symptoms
During episodes with mixed features, depressive symptoms may coexist with increased activation, agitation, or racing thoughts. Concentration and judgment may be affected by several changing clinical factors at once. Subthreshold mood symptoms can also persist outside a full episode. A cognitive score obtained during active symptoms should be interpreted in light of their severity and timing; a later comparison may be useful when symptoms have stabilized. NIMH · ISBD recommendations
Between episodes
The word stable describes a relative clinical state, not a promise that cognition has returned completely to an earlier baseline. Some people recover usual efficiency as sleep and mood settle. Others continue to report memory, concentration, or executive-function difficulties. The evidence for persistent group-level differences is robust, but the extent and causes of any individual's continuing symptoms remain questions for assessment. See Bipolar Disorder Recovery and Remission. Swidzinski et al., 2025
What Causes Cognitive Problems in Bipolar Disorder?
Episode symptoms and disrupted sleep
Mood episodes can change arousal, effort, attention, and the ability to encode new information. Sleep loss may add fatigue and lapses in concentration, while irregular timing can undermine routines. In an interview, chronology provides important evidence: did the problem begin with depression, after nights of curtailed sleep, following a hospitalization, or long before bipolar symptoms first appeared? Careful histories help distinguish temporary worsening from persistent difficulty and identify issues that can be addressed. NIMH · NICE guidance
Biological correlates, without simple explanations
Cognitive tasks depend on distributed networks involved in memory, control, and attention. Research has associated aspects of brain structure with performance in groups of participants with bipolar disorder. A systematic review and meta-analysis of structural imaging and cognitive measures reported associations, alongside methodological limitations and substantial variation. A routine scan cannot determine why one person experiences brain fog, and no single imaging marker functions as a clinical diagnostic test for bipolar cognitive impairment. Jones et al., 2025
The contemporary scientific picture includes potential contributions from genetic vulnerability, neural development, mood episodes, sleep, physical illness, psychosocial conditions, and treatment. Which pathways are causal, which are correlates, and which are effects of confounding remain active research questions. The 2026 state-of-the-field review highlights cognitive heterogeneity and the still-limited translation of experimental interventions into reliable everyday benefits. Miskowiak et al., 2026
Co-occurring conditions and general medical causes
ADHD, anxiety disorders, chronic insomnia, trauma-related problems, substance use, thyroid dysfunction, neurological conditions, and other physical illnesses can influence attention and memory. ADHD symptoms may begin in childhood and persist across settings; bipolar cognitive problems may fluctuate with episodes, though both disorders may coexist. The developmental history, episode timing, examination, and appropriate medical investigations help establish what needs care. Overlapping symptoms alone do not identify either condition. NICE assessment recommendations
Alcohol, cannabis, sedatives, and interactions among medications can affect alertness and task performance. Persistent cognitive problems deserve a review that considers diet and hydration, sensory limitations, sleep-disordered breathing, endocrine issues, and medications when indicated by the clinical presentation. There is no benefit in treating every new cognitive change as an inevitable manifestation of bipolar disorder when another treatable factor may be present. NICE
The benefits and cognitive adverse effects of medication
Bipolar medications have different roles in acute mania, bipolar depression, and maintenance prevention. Effective treatment may improve cognition indirectly by stabilizing episodes and reducing associated distress, while individual medicines may contribute sedation, tremor, fatigue, or complaints about mental clarity. Some antipsychotics add metabolic and sedation concerns; some anticonvulsants may produce tiredness. The balance depends on the medicine, dose, other prescriptions, medical status, and the individual's response. CANMAT/ISBD update · NICE medication recommendations
Lithium deserves specific monitoring. NICE recommends checking for neurotoxic symptoms such as ataxia, tremor, paresthesia, and cognitive impairment even at therapeutic lithium blood levels. New confusion, marked unsteadiness, vomiting, diarrhea, dehydration, severe illness, or rapidly worsening cognition in someone using lithium calls for timely medical review; the presence of ordinary forgetfulness alone does not prove lithium toxicity. Lithium levels, kidney and thyroid function, and other measurements should be monitored according to clinical guidance. Never stop, increase, restart, or reduce lithium independently. NICE lithium safety guidance
Lamotrigine requires careful titration because a serious rash can occur; valproate carries major reproductive and pregnancy-related risks and is subject to specialized restrictions; antipsychotics require side-effect monitoring; and antidepressants have bipolar-specific mood-switching considerations. Medication adjustments should be discussed with a qualified prescriber and should not sacrifice relapse protection on the basis of an unconfirmed explanation for brain fog. NICE · CANMAT/ISBD update
Does Bipolar Disorder Cause Progressive Memory Loss?
Longitudinal research does not establish inevitable, steady cognitive decline in everyone with bipolar disorder. A systematic review and meta-analysis comparing patient and control cognitive changes over extended follow-up found no significant overall difference in decline, with an average quantitative follow-up around nine years. It is a group-level finding. It does not exclude worsening in some people, nor does it rule out aging-related medical conditions or new neurological disease. Samamé et al., longitudinal review
A 2026 systematic review addressing illness progression found mixed evidence. Some cross-sectional studies associated longer illness duration or more episodes with poorer performance, while longitudinal findings often did not demonstrate comparable deterioration. Cross-sectional correlation cannot establish that episodes caused observed deficits: baseline characteristics, clinical severity, medication exposure, and other factors may differ. It is more useful to monitor actual individual change than to predict a fixed cognitive outcome from the years since diagnosis. 2026 illness-progression review
A new progressive problem warrants evaluation for reversible causes and possible neurocognitive conditions. Sudden altered awareness, severe confusion, focal neurological symptoms, or suspected medication toxicity require urgent medical attention. Older adults deserve particularly careful assessment because age, medication burden, vascular conditions, sensory loss, and independent neurodegenerative disorders can influence cognition. NICE assessment and prescribing guidance
How Are Memory, Attention, and Executive Problems Assessed?
Clinical interview and course history
A clinician begins by clarifying precisely what is happening, when it began, whether it varies across days or episodes, and how it affects daily tasks. The review includes lifetime mood episodes, residual symptoms, sleep, medical conditions, medication changes, substance use, family observations where appropriate, and education or work history. With the patient's agreement, information from a trusted person may help document changes during past episodes. NICE assessment guidance
Concrete examples improve assessment: a person misses two medical appointments despite reminders, needs twice as long to read familiar material, forgets several steps in a routine, or begins making uncharacteristic errors at work. Describe the previous baseline, frequency, consequences, and whether the difficulty appears only during poor sleep or mood change. This helps distinguish cognitive concern from a broad feeling of reduced confidence. ISBD clinical recommendations
Screening tools and their limits
The International Society for Bipolar Disorders Targeting Cognition Task Force recommends cognitive screening in partially or fully remitted patients whenever feasible. The Screen for Cognitive Impairment in Psychiatry (SCIP) assesses performance on brief tasks, whereas the Cognitive Complaints in Bipolar Disorder Rating Assessment (COBRA) gathers subjective complaints. These instruments can guide further assessment, but they cannot diagnose bipolar disorder, determine disability, or substitute for a clinician's full evaluation. Miskowiak et al., ISBD Task Force
Mood questionnaires such as the MDQ or HCL-32 address possible bipolar mood symptoms; they are different from cognitive performance tests. A positive score in either setting is a screening result requiring clinical interpretation. For their appropriate purpose, see Bipolar Disorder Screening Tests: MDQ, HCL-32, and Their Limitations.
When neuropsychological testing is useful
A formal neuropsychological examination can evaluate attention, speed, learning and memory, working memory, cognitive flexibility, and executive control using appropriate norms. Interpretation considers language, education, past cognitive ability, sensory or motor limitations, motivation, current mood, sleep, and medication effects. Referral is especially useful for persistent difficulties that interfere with work, education, finances, or independence, and for unusual or progressive patterns. ISBD recommendations
Testing also has limits. Scores reflect performance under particular conditions, often at a single visit. A normal result does not invalidate a reported change from a previously high level, and a low score by itself cannot establish that bipolar disorder caused it. Meaningful assessment integrates tests with patient-reported changes and practical demands. Eggleston et al., 2026 · Schandorff et al., 2026
Medical and medication safety review
Depending on symptoms, clinicians may consider targeted assessment of thyroid, metabolic, renal, neurological, or other medical contributors. For lithium, established monitoring includes serum levels and kidney and thyroid evaluation. Suspicion of toxicity or another acute medical problem warrants prompt assessment, even if psychiatric symptoms also occur. Medication and supplement lists should be reviewed for interactions. NICE lithium and medical monitoring
Cognition and Daily Life: What Changes in Practice?
Education, employment, and deadlines
Learning a new skill, participating in meetings, reading long texts, prioritizing projects, and completing work under time pressure place demands on memory, sustained attention, and cognitive flexibility. Performance may vary with the complexity of the task and the conditions under which it is done. Faster environments often expose difficulties that are less visible in calm settings. But the research association between cognition and functioning is modest: standardized scores are not a direct measure of someone's employability, intelligence, reliability, or worth. McCleery et al., 2026
Possible accommodations include written instructions, meeting agendas and summaries, fewer simultaneous tasks, protected uninterrupted work periods, extended preparation time, and predictable deadlines. These supports are tailored to the person's actual difficulty and context. Their aim is practical participation and reduced error, not a claim that a checklist cures a neurobiological condition.
Money, paperwork, and everyday decisions
Budgeting, paying bills, following medical plans, filing forms, and remembering appointments rely on prospective memory and executive functioning. Helpful systems can include one consolidated calendar, automatic reminders, scheduled bill payments where suitable, written medication plans, and double-checks before important transactions. During escalating mania, a previously agreed safety plan for major financial decisions may be important. VA/DoD guideline
Relationships and social participation
A person who becomes mentally overloaded may forget details from a conversation, need a question repeated, or struggle to follow several speakers. Loved ones may misinterpret these experiences as disinterest. Asking which kinds of support are useful, choosing quieter settings, and writing down agreed plans can ease misunderstandings. Relationship conflict also reflects interpersonal context, mood symptoms, and many other factors; it should not automatically be explained by cognition.
Confidence, autonomy, and identity
Changes in efficiency can affect self-confidence, particularly for people whose educational or professional identity is associated with rapid thinking. Supporting autonomy means identifying what the person wants to do, recognizing strengths, investigating treatable causes, and choosing accommodations collaboratively. Self-reported cognitive decline may have a meaningful relationship to quality of life even when scores are within population norms. Schandorff et al., 2026
For a wider framework for routines, employment, and relationships, see Living With Bipolar Disorder: Everyday Routines, Work, and Relationships.
Treatment and Cognitive Recovery: What Evidence Supports
Stabilizing the underlying mood disorder
The primary clinical task is effective phase-specific bipolar treatment: managing acute mania and bipolar depression, addressing mixed symptoms, and preventing future episodes. Appropriate pharmacotherapy, monitoring, and psychological care may reduce episode-related effects on concentration. Evidence for treating the mood disorder itself is stronger than evidence for a medicine that directly restores cognitive function in all phases of bipolar illness. Individual care plans should weigh symptom control, treatment adherence, physical health, and adverse effects. VA/DoD 2023 · CANMAT/ISBD update
Someone concerned about a medication's cognitive effects can bring a timeline of symptoms, sleep, dosages, and changes in daily performance to their prescriber. The clinician can review interactions, mood symptoms, laboratory results, and possible alternatives while protecting against relapse. The decision should not be reduced to choosing cognition or mood stability. See Bipolar Disorder Treatment and Bipolar Maintenance Treatment.
Psychotherapy, psychoeducation, and recovery planning
Psychoeducation, cognitive-behavioral approaches adapted to bipolar disorder, and family-focused work can support recognition of early warning signs, coping, routines, communication, and treatment engagement. Their evidence for selected mood and relapse outcomes must not be mistaken for proof that they reverse all neuropsychological deficits. Cognitive complaints can nonetheless become explicit functional goals within a broader individualized treatment plan. CANMAT/ISBD update · VA/DoD guideline
Strategies can include breaking a difficult project into steps, rehearsing a work sequence, reducing distractions, or designing reminders that fit the person's habits. These compensatory tools may be useful even when the biological mechanisms underlying the symptoms are not fully identified. For therapy approaches, read Psychotherapy for Bipolar Disorder: Psychoeducation, CBT, and Family Therapy.
Cognitive remediation and brain training
Cognitive remediation uses structured exercises, coaching, and strategies aimed at improving cognition or day-to-day functioning. A 2023 meta-analysis of seven independent randomized trials involving 586 participants found small improvements on selected cognitive measures, including working memory, planning, and verbal learning. Significant improvement in everyday functioning at completion or follow-up was not shown in that analysis. Thus, measured performance gains cannot yet be assumed to translate into broadly reliable real-world benefit. Samamé et al., 2023
A 2026 systematic review focusing on participants screened for cognitive dysfunction identified six eligible intervention studies. Outcomes were inconsistent: three studies reported statistically significant cognitive improvements, while three randomized trials did not. The studies were sufficiently heterogeneous that a pooled quantitative estimate was inappropriate. This supports continued research and individualized discussion, rather than routine promises that a commercial training program will restore bipolar-related cognition. Cartes et al., 2026
Medicines and supplements promoted as cognitive enhancers
No medicine or dietary supplement is established as a standard, generally effective treatment for bipolar-related cognitive impairment. Trials of candidate pharmacological and nutraceutical interventions have varied in populations, methods, outcomes, and safety. Some compounds can interact with bipolar medicines, affect sleep, or destabilize mood. A 2026 review highlights the preliminary character of the evidence. Consultation with the treating clinician is important before starting any additional supplement or stimulant-like product. Yalin and Yildiz, 2026
Everyday supports that can make a measurable difference
Regular sleep schedules, manageable task blocks, short written instructions, calendars, reminder systems, reduced distractions, and planned breaks offer practical ways to compensate for cognitive demands. They fit within comprehensive bipolar care and should be chosen on the basis of personal preference and observed benefit. An international bipolar cognition task-force resource also discusses sleep, alcohol, and compensatory strategies, while recognizing the continuing need for specific intervention evidence. ISBD Targeting Cognition Task Force
A useful way to evaluate a support strategy is to pick one repeated problem, make one realistic adjustment, and review the outcome after an agreed interval. For instance, track whether a combined calendar and alarm reduces missed appointments, or whether a written meeting summary improves follow-through. A strategy can be valuable because it helps a real task even when it does not change a neuropsychological test score.
A Practical Clinical Review Checklist
Bring examples of memory or attention failures, the approximate onset and frequency, current mood and sleep patterns, any recent medication changes, and questions about work or home functioning. Ask whether depression, hypomanic activation, an attention disorder, medical illness, or a medicine may be contributing. A shared plan may include monitoring, medical tests where appropriate, formal cognitive evaluation, a review of therapy or prescribing, and practical accommodations. NICE · ISBD recommendations
It is also helpful to identify which outcome matters most to the individual: completing coursework, remembering family commitments, returning to work, managing medications, or communicating more comfortably. Progress can then be judged against a meaningful functional goal rather than a global label of being sharp or impaired. Clinical evaluation of bipolar episodes is explained separately in How Is Bipolar Disorder Diagnosed?.
Specific Considerations for Different Age Groups
In children and adolescents, memory, attention, emotional regulation, and academic skills change with development. ADHD, sleep problems, learning differences, family circumstances, and other mental health conditions can overlap with bipolar presentations. Adult group estimates and adult intervention trials cannot be applied uncritically to a developing child. Specialist developmental assessment is important when an episodic bipolar presentation is suspected. NICE age-specific guidance
In older adults, changes in hearing or vision, cerebrovascular illness, medication burden, thyroid problems, and neurocognitive disorders may affect performance. New or progressive memory change deserves evaluation rather than automatic attribution to a prior bipolar diagnosis. Medication review may need to address sedation, anticholinergic effects, drug interactions, and greater vulnerability to adverse effects. NICE older-adult prescribing guidance
Pregnancy and the postpartum period require specialized bipolar care. Sleep loss, physical recovery, mood symptoms, and medications may influence concentration. Reproductive safety restrictions, particularly those involving valproate, must be considered by specialist prescribers rather than extrapolating from trials of cognition in nonpregnant adults. NICE clinical recommendations
When Should Cognitive Changes Prompt Urgent Care?
Urgent medical assessment is appropriate for new severe confusion, sudden disorientation, altered consciousness, neurological changes, suspected lithium toxicity, or other acute changes from the person's baseline. Rapidly escalating mania with very little sleep, psychotic symptoms, severe impulsivity, or inability to maintain basic safety also calls for urgent specialist attention. A clinician should distinguish an acute medical problem from mood symptoms rather than assuming either one explains everything. NICE · VA/DoD
If a person has suicidal thoughts with intent, a plan, or an inability to stay safe, contact emergency or crisis services immediately. In the United States, 988 is available by call or text for suicide and mental health crises; call 911 for an immediate medical emergency. Other countries have local crisis and emergency services. For bipolar-specific risk and planning, see Bipolar Disorder and Suicide Risk and Early Warning Signs of Mania and Bipolar Relapse.
Common Misconceptions
All people with bipolar disorder develop serious memory loss
Group comparisons show average cognitive differences, but individual profiles range from typical to more severe impairment. A meta-analytic average says little about the functioning of one person without an individual assessment. Bora et al., 2025
Stable mood means the brain must perform exactly as before
Interepisode cognitive difficulties are documented. Residual mood symptoms, medications, sleep and other contributors should still be examined before attributing any change to the bipolar illness itself. Swidzinski et al., 2025
Forgetfulness proves the disease is progressively damaging the brain
Longitudinal studies do not establish inevitable decline for all patients. An important new memory problem should be evaluated, but it cannot by itself demonstrate a progressive biological process. Samamé et al., longitudinal review · 2026 progression review
Brain training and supplements are proven cognitive treatments
Controlled trials show some promising findings but inconsistent cognitive outcomes and limited demonstrated improvement in daily functioning. Practical coping tools can help specific tasks without constituting an established disease-modifying intervention. Samamé et al., 2023 · Cartes et al., 2026
Frequently Asked Questions
Can bipolar disorder cause memory loss?
Bipolar disorder is associated with differences in learning, verbal recall, visual memory, and working memory in some people, including during euthymia. Memory complaints may also involve poor initial attention or sleep and medication effects. Clinical assessment determines which explanations apply. Swidzinski et al., 2025
Why can't I concentrate even though I am not depressed or manic?
Some people experience persistent interepisode cognitive differences. Residual symptoms, sleep, other psychiatric or medical conditions, and medication adverse effects also need review. A detailed timeline and selected screening or neuropsychological testing can clarify the problem. ISBD recommendations
Does bipolar II cause less cognitive impairment than bipolar I?
The categories differ in their history of mania and hypomania, rather than in a simple hierarchy of cognitive severity. Research finds heterogeneous outcomes and substantial overlap. An individual's cognitive profile should be assessed directly instead of inferred from subtype. Bora et al., 2025
Is bipolar brain fog the same as ADHD?
Both may involve distraction and executive difficulties, and both can coexist. ADHD usually involves a long-standing developmental pattern, whereas bipolar disorder requires recognizable mood episodes over time. Sleep, depression, anxiety, medication effects, and other diagnoses also need consideration. NICE assessment recommendations
Can lithium cause cognitive problems?
Some people report changes in thinking while taking lithium, but effects and causes vary, and lithium can be important for long-term mood stability. NICE recommends monitoring neurotoxicity symptoms, including cognitive impairment, even with therapeutic levels. New confusion or unsteadiness warrants prompt medical review, and the medicine should not be changed independently. NICE lithium guidance
Can cognition improve after a bipolar episode?
Yes. Mood stabilization, improved sleep, and treatment of associated problems may ease episode-related difficulties. Some people also continue to experience cognitive concerns in remission. The degree and timing of change differ between individuals. NIMH · Swidzinski et al., 2025
Does bipolar disorder inevitably lead to dementia?
No. Cognitive complaints or a bipolar diagnosis do not establish dementia. Longitudinal evidence does not show universal progressive decline, while older adults may develop independent neurological or other medical conditions. Progressive impairment should receive proper assessment. Longitudinal meta-analysis
Do cognitive remediation apps work?
Evidence remains mixed. Some research reports small test-score improvements, but consistent gains in functional outcomes have not been established. Commercial claims of guaranteed improvement go beyond the current evidence. Samamé et al., 2023 · Cartes et al., 2026
What can family members do about forgetfulness?
Ask what support the person welcomes, identify specific recurring problems, and offer tools such as written plans or shared reminders. Encourage review of any new deterioration, and seek urgent care for severe confusion or threats to safety. Support should preserve the person's voice and practical autonomy. For daily-life considerations, see Living With Bipolar Disorder.
Related Articles
References
Bora, E., et al. (2025). A meta-analysis of data-driven cognitive subgroups in bipolar disorder. European Neuropsychopharmacology. DOI
Cartes, B., Solari, T., Vöhringer, P., & Nieto, R. R. (2026). Cognitive remediation in people with bipolar disorder and cognitive dysfunction: A systematic review. Journal of Psychiatry & Neuroscience. DOI
Eggleston, K., et al. (2026). Systematic review and meta-analysis of the association between subjective and objective cognitive function in mood disorders. Bipolar Disorders. DOI
International Society for Bipolar Disorders. (n.d.). Targeting Cognition Task Force: Resources on cognitive difficulties in bipolar disorder. Official source
Ji, I. S., Teopiz, K. M., Cheung, W., & McIntyre, R. S. (2026). Cognitive decline and illness progression in bipolar disorder. Advances in Therapy, 43, 1439–1485. Official source
Jones, B. D. M., et al. (2025). Associations between structural brain measures and cognitive function in bipolar disorder: A systematic review and meta-analysis. Neuropsychopharmacology. Journal
Keramatian, K., Chithra, N. K., & Yatham, L. N. (2023). The CANMAT and ISBD guidelines for the treatment of bipolar disorder: Summary and a 2023 update of evidence. Focus. DOI
Little, B., Anwyll, M., Norsworthy, L., Corbett, L., Schultz-Froggatt, M., & Gallagher, P. (2024). Processing speed and sustained attention in bipolar disorder and major depressive disorder: A systematic review and meta-analysis. Bipolar Disorders, 26(2), 109–128. DOI
McCleery, A., Hellemann, G. S., & Lee, J. (2026). Relationships between cognition and daily functioning in adults with bipolar disorder: A systematic review and multilevel meta-analysis. Psychological Bulletin, 152, 326–348. DOI
Miskowiak, K. W., et al. (2018). Assessing and addressing cognitive impairment in bipolar disorder: International Society for Bipolar Disorders Targeting Cognition Task Force recommendations for clinicians. Bipolar Disorders. DOI
Miskowiak, K. W., Kjærstad, H. L., Vieta, E., & Yatham, L. N. (2026). Insights, challenges and new frontiers for cognitive function in bipolar disorder. Nature Mental Health, 4, 521–539. Journal
National Institute for Health and Care Excellence. (2014, updated). Bipolar disorder: Assessment and management (CG185). Guideline
National Institute of Mental Health. (n.d.). Bipolar disorder. Official overview
Samamé, C., Durante, P., Cattaneo, B., Aprahamian, I., & Strejilevich, S. (2023). Efficacy of cognitive remediation in bipolar disorder: Systematic review and meta-analysis of randomized controlled trials. Psychological Medicine. DOI
Samamé, C., et al. (2022). The long-term course of cognition in bipolar disorder: A systematic review and meta-analysis of patient–control differences in test-score changes. Psychological Medicine. PubMed
Schandorff, J. M., et al. (2026). Cognitive complaints in bipolar disorder: Relation to estimated illness-related objective cognitive decline, functioning, and quality of life. Bipolar Disorders. DOI
Swidzinski, S., et al. (2025). Domain-specific cognitive function in euthymic bipolar disorder: A systematic review and meta-analysis. Psychological Medicine, 55, e336. DOI
U.S. Department of Veterans Affairs & U.S. Department of Defense. (2023). Clinical practice guideline for management of bipolar disorder. Clinical guideline
Yalin, N., & Yildiz, A. (2026). Improving cognition in bipolar disorder: A systematic review of current pharmacological and nutraceutical approaches. Neuropsychobiology. DOI